Metadata Search
Page 1 of 4 results
Sort by: relevance publication year Download as CSV

Secreted amyloid precursor protein alpha activates neuronal insulin receptors and prevents diabetes-induced encephalopathy

Journal Article published May 2018 in Experimental Neurology volume 303 on pages 29 to 37

Research funded by Canadian Diabetes Association | Alzheimer's Society of Canada, Manitoba Health Research | St Boniface Hospital Research Foundation (SBHF-7069) | Canadian Institutes of Health Research (RPA-113765) | Alzheimer Society of Manitoba | McCrorie-West Family

Authors: Brent D. Aulston, Jason Schapansky, YaWen Huang, Gary L. Odero, Gordon W. Glazner

Strain differences in hippocampal synaptic dysfunction in the TgCRND8 mouse model of Alzheimer's disease: Implications for improving translational capacity

Journal Article published Jan 2019 in Molecular and Cellular Neuroscience volume 94 on pages 11 to 22

Research funded by St. Boniface Hospital Research Foundation (1406-3216, 1410-3216) | Alzheimer Society of Manitoba | The Honourable Douglas and Patricia Everett and Royal Canadian Properties Limited Endowment Fund (1403-3131)

Authors: Wanda M. Snow, Kensuke Oikawa, Jelena Djordjevic, Benedict C. Albensi

A review of clinical treatment considerations of donepezil in severe Alzheimer's disease

Journal Article published 29 Jul 2018 in CNS Neuroscience & Therapeutics volume 24 issue 10 on pages 876 to 888

Research funded by Research Manitoba | St. Boniface Hospital Research Foundation (1406-3216, 1410-3216) | Alzheimer Society of Manitoba | The Honourable Douglas and Patricia Everett and Royal Canadian Properties Limited Endowment Fund (1403-3131)

Authors: Aida Adlimoghaddam, Melanie Neuendorff, Banibrata Roy, Benedict C. Albensi

Distinct brain metabolic patterns separately associated with cognition, motor function, and aging in Parkinson's disease dementia

Journal Article published Dec 2017 in Neurobiology of Aging volume 60 on pages 81 to 91

Research funded by Neurotrack Technologies | National Institute of Biomedical Imaging and Bioengineering | Novartis Pharmaceuticals Corporation | CereSpir, Inc | Canadian Institutes of Health Research | Janssen Alzheimer Immunotherapy Research & Development, LLC | Pfizer | AbbVie | Cogstate | Bristol-Myers Squibb | University of Manitoba | Eisai | National Institute on Aging | Euroimmun | Ministry of Education and Science of Korea | U.S. Department of Defense (W81XWH-12-2-0012) | King Saud University | Lundbeckfonden | Lumosity | Elan Pharmaceuticals, Inc | IXICO Ltd | National Institutes of Health | Piramal Imaging | Fondation Brain Canada | Takeda Pharmaceutical Company | Alzheimer Society of Manitoba | Transition Therapeutics | Servier | Alzheimer's Disease Neuroimaging Initiative (U01 AG024904) | Genentech | Johnson and Johnson | Meso Scale Diagnostics | GE Healthcare | Eli Lilly and Company | Asan Institute for Life Sciences | Biogen | Natural Sciences and Engineering Research Council of Canada | Roche | Merck | Fujirebio Europe | Dr Paul H. T. Tholakson Foundation | Araclon Biotech | Alzheimer's Drug Discovery Foundation | Alzheimer's Association | NeuroRx Research | Manitoba Medical Services Foundation | BioClinica

Authors: Ji Hyun Ko, Audrey Katako, Maram Aljuaid, Andrew L. Goertzen, Andrew Borys, Douglas E. Hobson, Seok Min Kim, Chong Sik Lee